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Background: Eps15 is an endocytic adaptor protein that stimulates clathrin-mediated endocytosis. Among other
interactions, Eps15 binds ubiquitin via UIM domains, recruiting ubiquitinated cargo into clathrin-coated vesicles. In
EGF-treated cells, Eps15 also localizes to endosomes. The basis of this localization is not known.
Results: We show that accumulation of ubiquitinated cargo can recruit Eps15 to endosomes via UIM domain
interactions. First, treatment of SK-Br-3 breast cancer cells, which overexpress the EGFR family member ErbB2, with
geldanamycin to promote receptor ubiquitination and endosomal transport, recruited FLAG-Eps15 to endosomes.
Two in-frame ubiquitin constructs, PM-GFP-Ub (retained in endosomes after endocytosis), and GFP-FYVE-UbΔGG
(targeted directly to endosomes) also recruited Eps15 to endosomes, as did slowing endosome maturation with
constitutively-active Rab5-Q79L. Endosomal recruitment required the UIM domains, but not the N-terminal EH
domains or central coiled-coil domains, of Eps15. Silencing of the endosomal Eps15 binding partner Hrs did not
affect recruitment of Eps15 to ubiquitin-enriched endosomes. In fact, Hrs silencing itself modestly recruited Eps15 to
endosomes, probably by accumulating endogenous ubiquitinated cargo. Eps15 silencing did not affect lysosomal
degradation of ubiquitinated ErbB2; however, GFP-FYVE-UbΔGG overexpression inhibited internalization of EGFR
and transferrin receptor.
Conclusions: We show for the first time that ubiquitin is sufficient for Eps15 recruitment to endosomes. We
speculate that Eps15 recruitment to ubiquitin-rich endosomes may reduce the level of Eps15 at the plasma
membrane, slowing endocytosis to allow time for processing of ubiquitinated cargo in endosomes.
Keywords: Endocytosis, Early endosome, Ubiquitin-interacting motif, Receptor down-regulationBackground
Clathrin-mediated endocytosis is used for selective intern-
alization of specific plasma membrane proteins, in func-
tions that include nutrient uptake and down-regulation of
signaling receptors [1-3]. Clathrin provides the structural
framework for the coat surrounding internalized vesicles,
while a complex array of adaptor proteins are required
both for coat formation and for recruiting specific cargo
proteins to vesicles [3].
One such adaptor protein, Eps15, plays a key role in
clathrin-mediated endocytosis [3,4]. Eps15 is a modular* Correspondence: azad.gucwa@liu.edu; deborah.brown@stonybrook.edu
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article, unless otherwise stated.protein. Three N-terminal Eps15 homology (EH) domains
bind NPF motifs on a variety of other endocytic adaptor
proteins [5]. A central coiled-coil domain mediates Eps15
oligomerization [6] and binding to other proteins in-
cluding intersectin [7] and the Met receptor [8]. Eps15
contains a domain of DPF repeats that bind AP-2, an
abundant adaptor protein that links cargo and clathrin
[3,9]. Two ubiquitin interacting motifs (UIM domains)
are located near the C-terminus of Eps15 [10].
Eps15 is localized at the rims of clathrin-coated pits
[11-13], and is thought to participate in formation of the
clathrin lattice. Consistent with this idea, dominant-
negative Eps15 constructs inhibit endocytosis of diverse
cargoes, including transferrin receptor and the epidermal
growth factor receptor (EGFR) [14]. Furthermore, Eps15entral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
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thrin adaptor AP180 [15].
In addition to this general role in clathrin coat assembly,
Eps15 has a special relationship with EGFR and other ubi-
quitinated endocytic cargo. Eps15 was originally identified
as an EGFR substrate [16], and is phosphorylated by EGFR
on Tyr 850 [17]. Overexpression of an Eps15 mutant lack-
ing this residue blocks endocytosis of the EGFR, but not
the transferrin receptor [17]. Although a substantial pool
of Eps15 is constitutively present at the plasma mem-
brane, additional Eps15 is recruited there in response to
EGFR signaling [18,19]. UIM domain-dependent binding
of Eps15 to EGFR and other ubiquitinated proteins at the
plasma membrane has been proposed to recruit ubiquiti-
nated proteins to clathrin-coated pits and facilitate their
endocytosis [19-23].
Ubiquitin binding by Eps15 may play another role in
endocytosis as well. In addition to binding ubiquitin via
UIM domains, Eps15 and other endocytic adaptor proteins
(Eps15R and epsins) are themselves mono-ubiquitinated
[10]. These proteins can bind each other via ubiquitin-
UIM interactions and through other motifs [4], suggesting
the existence of a UIM-ubiquitin-based protein network
at endocytic sites [10]. Formation of this network could
enhance endocytosis by increasing the local concentration
of these proteins. In yeast, formation of such a network
has been proposed to be the main function of ubiquitin-
binding interactions of epsins and the Eps15-like protein
Ede1 [24].
Eps15 can localize to endosomes as well as the plasma
membrane [18,19,25-27]. Eps15 is essentially undetectable
in endosomes in resting cells [11,28,29], but is recruited
there following EGFR signaling [18,19]. The function of
endosomal Eps15 is not clear, and it is not known how
EGFR signaling targets the protein there. Endosomal re-
cruitment might require tyrosine phosphorylation, either
of Eps15 itself or another EGFR substrate. Alternatively,
as activation of EGFR results in ubiquitination and endo-
somal delivery of the receptor [30], Eps15 might be re-
cruited to endosomes by binding of its UIM domains to
ubiquitinated EGFR. In either case, it is not known
whether endosomal recruitment of Eps15 requires Hrs.
Hrs, together with its binding partner STAM, forms the
ESCRT-0 complex that binds ubiquitinated cargo upon its
delivery to endosomes, and then passes it on to down-
stream ESCRT complexes for eventual degradation in ly-
sosomes [30]. Eps15 can bind Hrs [27,31], but the role of
this interaction in EGF-dependent endosomal recruitment
of Eps15 is not entirely known. Recently, it was found that
in C. elegans, ESCRT-0 might be recruited to ubiquiti-
nated cargo at the plasma membrane where it directly in-
teracts with the Eps15 homolog EHS-1, suggesting a more
complex relationship with the endosomal sorting machin-
ery than previously imagined [32].A novel Eps15 splice variant named Eps15b was re-
cently discovered [29]. The N-terminal EH domains
present in Eps15 are replaced by a short unique se-
quence in Eps15b, but the two proteins are otherwise
identical. Unlike Eps15, which is largely restricted to the
plasma membrane in resting cells, Eps15b is constitu-
tively localized to endosomes, apparently in a complex
with Hrs [29]. Eps15b promotes EGFR degradation, pre-
sumably through ubiquitin-dependent binding to EGFR
[29].
In this paper, we tested the role of ubiquitinated cargo
in endosomal recruitment of full-length Eps15. We ex-
amined three ubiquitinated proteins that can accumulate
in endosomes in the absence of EGFR or other tyrosine
kinase activity. The first was the EGFR family member
ErbB2. Constitutive binding of ErbB2 to the chaperone
Hsp90 is required for its stability: ErbB2 is ubiquitinated,
internalized by a clathrin-independent pathway [33], and
targeted to multi-vesicular bodies (MVBs) independently
of signaling activity when cells are treated with the ansa-
mycin antibiotic geldanamycin, which releases Hsp90
from ErbB2 and its other client proteins [34,35]. We also
examined two hybrid proteins containing membrane-
targeting signals linked to plasmid-encoded ubiquitin [36].
PM-GFP-Ub is initially targeted to the plasma membrane,
but accumulates in endosomes following constitutive in-
ternalization, while GFP-FYVE-UbΔGG is targeted dir-
ectly to early endosomes via a PI(3)P-binding FYVE
domain [36]. We found that Eps15 was recruited to
ubiquitin-rich endosomes in all three cases. Recruitment
did not require Hrs, but did require the UIM domains of
Eps15. Together, these results suggest that Eps15 can be
recruited to ubiquitin-rich endosomes via UIM-domain
interactions.
This behavior is similar to that of epsin, another UIM-
domain containing endocytic adaptor protein that can be
recruited to ubiquitin-rich endosomes [36]. However,
epsin is only recruited to endosomes when its normal
binding to clathrin is prevented [36]. By contrast, FLAG-
Eps15 was recruited to endosomes regardless of expres-
sion levels, and without perturbation of other binding
interactions, suggesting a physiologically relevant role.
Thus, recruitment of Eps15 to ubiquitin-rich endosomes
may act as a rheostat, slowing endocytosis and giving the
ESCRT machinery time to process ubiquitinated cargo in
endosomes.
Results
FLAG-Eps15 is recruited to endosomes in GA-treated SK-
BR-3 cells
ErbB2 is expressed at high levels on the plasma membrane
of SK-BR-3 breast cancer cells (Figure 1A). Transfected
FLAG-Eps15 localized to the cytosol and small puncta in
these cells, as expected (Figure 1A). GA induces ErbB2
Figure 1 (See legend on next page.)
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Figure 1 FLAG-Eps15 is recruited to endosomes enriched in ubiquitinated ErbB2 in a UIM-domain-dependent manner. A, B. FLAG-
Eps15-transfected SK-BR-3 cells were treated with DMSO (A) or 5 μM GA (B) for 4 hours, and then processed for IF, detecting FLAG-Eps15 with
anti-FLAG antibodies and endogenous ErbB2 with anti-ErbB2 antibodies. C-F. COS-7 cells transfected with FLAG-Eps15 or FLAG-Eps15-ΔUIM,
together with GFP or ErbB2-GFP as indicated, were treated with 5 μM GA for 4 hours and then processed for IF, detecting FLAG-Eps15 constructs
with anti-FLAG antibodies. G. Colocalization of FLAG-Eps15 or FLAG-Eps15-ΔUIM with EEA1 in COS-7 cells co-expressing either GFP or GFP-ErbB2
and treated with DMSO or 5 μM GA for 4 hours was quantified using NIH ImageJ. The Manders’ overlap coefficient is shown. Values shown are
the average of at least 10 cells in each of 3 experiments, +/− standard error of the mean (SEM). The data were compared using a one-way ANOVA
test (***p < 0.0001). Scale bars; 10 μm.
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tion, and transport to early and late endosomes and lyso-
somes, where it can be detected by immunofluorescence
(IF) microscopy [33,37]. Endosomal accumulation of
ErbB2 is easily detected by immunofluorescence after
4 hours of GA treatment, as a significant proportion of
the receptor has either degraded or relocalized from the
plasma membrane to endosomes. Upon GA treatment of
transfected SK-BR-3 cells, FLAG-Eps15 re-localized to
endocytic organelles, where it colocalized with internal-
ized endogenous ErbB2 (Figure 1B).
To study this behavior further, we expressed wild-type
or mutant FLAG-Eps15 in COS-7 cells, and examined
colocalization with the early endosome marker EEA1
under various conditions, quantitating the colocalization
as described in Methods. When expressed alone (not
shown) or together with GFP (Figure 1C), FLAG-Eps15
had a fine punctate distribution, as in SK-BR-3 cells, both
with (Figure 1C, G) and without (Figure 1G) GA. In agree-
ment with earlier reports [11,28,29], very little FLAG-
Eps15 was present on early endosomes (Figure 1C, G).
When FLAG-Eps15 was co-expressed with GFP-tagged
ErbB2 in these cells, Eps15 localization was similar to
that in cells co-expressing GFP, with little endosomal
localization (image not shown; quantitation in Figure 1G).
However, after GA treatment, both Eps15 and ErbB2-
GFP were strongly recruited to endosomes (Figure 1D, G).
This required the UIM domains of Eps15, as a construct
lacking these domains [38] did not localize to endosomes
even when co-expressed with ErbB2-GFP in GA-treated
cells (Figure 1, E-G). Together, these results showed that
Eps15 was recruited to endosomes when ubiquitinated
ErbB2 accumulated there, in a UIM domain-dependent
manner.
To determine whether the endosomal recruitment of
Eps15 is related to activation of the EGFR signaling
pathway, we treated SK-BR-3 cells with either EGF or
GA for 0, 4 or 8 hours and looked for an increase in
phosphorylated Akt or MAPK (Additional file 2: Figure S2).
We found that GA did not affect total MAPK levels. As
noted previously [39,40], GA destabilized Akt. However,
GA did not stimulate phosphorylation of either Akt or
MAPK, suggesting that GA-induced recruitment of Eps15
to endosomes did not require EGFR signaling.Eps15 is recruited to endosomes containing PM-GFP-Ub
As GA releases Hsp90 from many proteins [35], it was
possible that endosomal recruitment of Eps15 depended
on effects that were independent of ErbB2. To provide
more direct evidence that ubiquitinated cargo could re-
cruit Eps15 to endosomes, we examined cells expressing
PM-GFP-Ub. This construct encodes ubiquitin fused to
GFP and to a dually-acylated plasma membrane target-
ing signal derived from the Src-family kinase Lyn
[36,41]. Although PM-GFP-Ub is initially targeted to the
plasma membrane, it also accumulates in endosomes,
probably by ubiquitin-dependent trapping by the ESCRT
machinery following endocytosis ([36] and Figure 2). By
contrast, PM-GFP, which lacks plasmid-encoded ubiqui-
tin, is not enriched in endosomes. We found that FLAG-
Eps15 accumulated on endosomes in cells expressing
PM-GFP-Ub, but not in cells expressing PM-GFP, in a
UIM-dependent manner (Figure 2).
Eps15 is recruited to endosomes containing
GFP-FYVE-UbΔGG
As PM-GFP-Ub is initially targeted to the plasma mem-
brane, it was possible that components required for endo-
somal recruitment of Eps15 in PM-GFP-Ub-expressing
cells – or Eps15 itself - might be transported from the
plasma membrane to endosomes together with PM-GFP-
Ub. For this reason, we next examined GFP-FYVE-
UbΔGG. This construct consists of ubiquitin (lacking the
last two residues, in order to prevent linkage of additional
ubiquitin moieties) fused to GFP and to the FYVE domain
of Hrs, which targets the protein directly from the cytosol
to PI(3)P-rich endosomes [36]. When co-expressed in
COS-7 cells, FLAG-Eps15 accumulated together with
GFP-FYVE-UbΔGG on EEA1-positive endosomes
(Figure 3C, top), providing further support for the idea
that Eps15 was recruited directly to ubiquitin-rich
endosomes.
Surprisingly, some Eps15 was recruited to endosomes in
cells expressing GFP-FYVE itself (not shown). We specu-
late that over-expression of this construct disrupted endo-
some function by competing with endogenous FYVE
domain proteins–including Hrs–for endosome binding.
This would cause accumulation of endogenous ubiquiti-
nated cargo in endosomes, recruiting Eps15.
Figure 2 PM-GFP-Ub recruits FLAG-Eps15 to early endosomes in a UIM-domain-dependent manner. A-D. COS-7 cells transfected with
FLAG-Eps15 or FLAG-Eps15-ΔUIM, together with PM-GFP or PM-GFP-Ub as indicated, were processed for IF, detecting FLAG-Eps15 constructs with
anti-FLAG antibodies. E. Colocalization of FLAG-Eps15 or FLAG-Eps15-ΔUIM with EEA1 in COS-7 cells co-expressing either PM-GFP or PM-GFP-Ub
was determined and is presented as in Figure 1C, averaging values for at least 10 cells in each of 3 experiments, +/− SEM. The data were
compared using a one-way ANOVA test (***p < 0.0001). Scale bars; 10 μm.
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required for Eps15 recruitment to ubiquitin-rich
endosomes
Because GFP-FYVE-UbΔGG recruited Eps15 to endo-
somes efficiently, without possible complications of deliv-
ery from the plasma membrane, we used it in further
studies to characterize this recruitment in more detail. We
could not detect endogenous Eps15 by IF with our anti-
bodies, and we were concerned that endosomal recruit-
ment of FLAG-Eps15 might only occur at high expression
levels, after saturation of normal binding interactions.
For this reason, we measured endosomal recruitment ofFLAG-Eps15 in GFP-FYVE-UbΔGG-expressing COS-7
cells as a function of the level of expression of FLAG-
Eps15. Colocalization of FLAG-Eps15 with EEA1 did
not correlate with Eps15 expression: FLAG-Eps15 was
recruited efficiently to endosomes even in cells with the
lowest detectable FLAG-Eps15 level (Additional file 3:
Figure S3).
To exclude a possible role for the FLAG tag in endoso-
mal recruitment of Eps15, we showed that mCherry-
Eps15 was also recruited to endosomes in cells expressing
either PM-GFP-Ub or GFP-FYVEΔGG (Additional file 4:
Figure S4).
Figure 3 FLAG-Eps15 recruitment to GFP-FYVE-UbΔGG-enriched endosomes requires UIM, but not EH or coiled-coil domains. A.
Schematic diagram of the Eps15 mutants used. B. FLAG-Eps15 (Eps15) or the indicated FLAG-Eps15 mutant was expressed in COS-7 cells. Proteins in
cell lysates (equal volumes) were separated by SDS-PAGE and analyzed by Western blotting, probing with anti-FLAG antibodies. The blot was then
probed with anti-Hsp70 antibodies to verify equal loading. C. Wild-type FLAG-Eps15 (Eps15) or the indicated FLAG-Eps1 mutant was expressed in
COS-7 cells together with GFP-FYVE-UbΔGG. Cells were processed for IF, detecting the FLAG-Eps15 proteins with anti-FLAG and then AF-594 goat
anti-rabbit antibodies, and EEA1 with anti-EEA1 and then AF-647 goat anti-mouse antibodies. From left to right in each row, anti-FLAG staining,
anti-EEA1-staining (pseudo-colored blue), GFP fluorescence, and a merged image are shown. Scale bars; 10 μm. D. Wild-type or mutant FLAG-Eps15
was co-expressed with GFP or GFP-FYVE-UbΔGG as indicated, and processed for fluorescence microscopy as in C. Colocalization analysis of the
FLAG-Eps15 proteins with EEA1 was performed as in Figure 1. Values shown are the average of 2 experiments, +/− SEM. The data were compared
using a one-way ANOVA test (***p < 0.0001, **p < 0.005).
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domains, are required for recruitment to ubiquitin-
containing endosomes
We next mapped the region(s) of Eps15 required for re-
cruitment to ubiquitin-enriched endosomes using a series
of FLAG-Eps15 deletion mutants. FLAG-Eps15-ΔI lacks
the N-terminal EH domains, while FLAG-Eps15-ΔII is an
internal deletion lacking the central coiled-coil domain
([42]; schematized in Figure 3A). FLAG-Eps15-ΔIII,
FLAG-Eps15-ΔIV, and the FLAG-Eps15-ΔUIM construct
used in Figures 1 and 2 are C-terminal truncation mu-
tants: FLAG-Eps15-ΔIII lacks most of the DPF-repeat re-
gion required for AP-2 binding and the UIM domains,
while both FLAG-Eps15-ΔIV and FLAG-Eps15-ΔUIM
lack the UIM domains ([38,42]; Figure 3A). Except for
FLAG-Eps15-ΔIV, which for unknown reasons was poorly
expressed, the constructs were expressed at similar levels
in COS-7 cells (Figure 3B).We next expressed the Eps15 constructs together with
GFP or GFP-FYVE-UbΔGG in COS-7 cells and measured
colocalization of the Eps15 proteins with EEA1. Selected
images are shown in Figure 3C, and quantitation of the
colocalization is shown in Figure 3D. FLAG-Eps15-ΔI and
FLAG-Eps15-ΔII were recruited quite efficiently to endo-
somes in cells expressing GFP-FYVE-UbΔGG, showing
that the EH and coiled-coil domains were not essential for
endosomal localization (Figure 3C, D). The modest de-
crease in endosomal recruitment of FLAG-Eps15-ΔII,
compared to wild-type Eps15, might result from the in-
ability of this construct to oligomerize [43]. As UIM do-
mains bind ubiquitin with low affinity [44], oligomeric
Eps15 would be expected to bind more strongly to
ubiquitin-rich endosomes than monomeric Eps15, even if
binding occurred only through UIM-ubiquitin interac-
tions. By contrast, constructs lacking the UIM domains
(FLAG-Eps15-ΔIII, FLAG-Eps15-ΔIV, and FLAG-Eps15-
Figure 4 (See legend on next page.)
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Figure 4 Hrs is not required for recruitment of Eps15 to GFP-FYVE-UbΔGG or endogenous ubiquitinated cargo. COS-7 cells were
transfected with siRNA targeting Hrs or control siRNA, and also with plasmids encoding FLAG-Eps15 and GFP-FYVE-UbΔGG. A. Proteins in lysates
(equal volumes from each sample) were separated by SDS-PAGE and then analyzed by Western blotting, probing with anti-Hrs antibodies (top) or
anti-Hsp70 antibodies as a loading control (bottom). B. Bands on the blot shown in Panel A were quantitated by densitometry, normalizing to
the signal in the control sample. C. Cells transfected with the indicated constructs were processed for IF microscopy, staining with anti-FLAG and
AF-594 goat anti-rabbit IgG to detect FLAG-Eps15 and with anti-Hrs and AF-647 goat anti-mouse IgG to detect Hrs (pseudo-colored blue). D, E.
COS-7 cells transfected with control siRNA (D) or Hrs siRNA-2 (E) and with FLAG-Eps15 were processed for IF microscopy, detecting FLAG-Eps15
with anti-FLAG antibodies and AF-488 goat anti-rabbit IgG, and EEA1 with anti-EEA1 antibodies and AF-594 goat anti-mouse IgG. F, G. COS-7 cells
co-transfected with FLAG-Eps15 together with either GFP or GFP-Rab5Q79L were processed for IF microscopy, detecting FLAG-Eps15 with anti-
FLAG antibodies and AF-594 goat anti-rabbit IgG, and EEA1 with anti-EEA1 antibodies and AF-647 goat anti-mouse IgG (pseudo-colored blue).
Merged images are shown at the right. Scale bars; 10 μm.
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endosomal recruitment (Figure 3C, D).
Tyr 850 is not required for endosomal recruitment of
FLAG-Eps15
The EGFR phosphorylates Eps15 on Tyr 850 [17]. To de-
termine whether this modification is required for endoso-
mal recruitment, we co-expressed a non-phosphorylatable
Eps15 mutant, Eps15-Y850F, with GFP or GFP-FYVE-
UbΔGG in COS-7 cells. In cells expressing GFP, Eps15-
Y850F had the same punctate localization as wild-type
FLAG-Eps15, and was not present on EEA1-positive
endosomes (Additional file 5: Figure S5, top row). How-
ever, Eps15-Y850F was efficiently recruited to endosomes
in cells expressing GFP-FYVE-UbΔGG (Additional file 5:
Figure S5) as well as those containing activated EGFR
(Additional file 6: Figure S6, bottom panel). This showed
that tyrosine phosphorylation on Tyr 850 is not required
for endosomal localization of Eps15.
Hrs is not required for ubiquitin-dependent recruitment
of Eps15 to early endosomes
Hrs can bind Eps15 in the cytosol and on endosomes.
Eps15b, which localizes primarily to endosomes even
without ubiquitin enrichment, binds Hrs in vivo [29].
Furthermore, Eps15b localizes to Hrs-positive endosome
microdomains, suggesting that Hrs recruits Eps15b to
endosomes [29]. Eps15 can also bind Hrs [27,31], though
this interaction does not occur at significant levels in
cells with normal, low levels of endosomal ubiquitin
[29]. For this reason, we next suppressed Hrs expression
with siRNA to determine whether Hrs were required for
ubiquitin-dependent endosomal recruitment of Eps15.
We first verified that Hrs expression was efficiently sup-
pressed (by about 90%) by siRNAs targeting two differ-
ent sequences in human Hrs (Hrs siRNA-1 and Hrs
siRNA-2), both in human HeLa cells (not shown) and in
COS-7 cells (Figure 4A, B). We then co-expressed
FLAG-Eps15 and GFP-FYVE-UbΔGG, in COS-7 cells
previously transfected with either Hrs siRNA-1 or a con-
trol siRNA (Figure 4C). In agreement with the Western
blot data (Figure 4A, B), Hrs was easily detectable onendosomes in control cells, but not in cells expressing Hrs
siRNA-1. (The anti-Hrs antibodies sometimes stained nu-
clei non-specifically, as seen in Figure 4C). FLAG-Eps15
was recruited efficiently to GFP-FYVE-UbΔGG, PM-GFP-
Ub and ErbB2-GFP enriched endosomes even in cells with
no detectable Hrs, showing that Hrs was not required for
ubiquitin-dependent endosomal recruitment of Eps15
(Figure 4C). Similar results were obtained in cells express-
ing Hrs siRNA-2 instead of Hrs siRNA-1 (not shown).
Furthermore, Hrs silencing did not affect FLAG-Eps15 re-
cruitment to endosomes in COS7 cells expressing PM-
GFP-Ub, or in GA-treated SK-BR-3 cells (Additional file 7:
Figure S7).
FLAG-Eps15 is recruited to endosomes enriched in
endogenous ubiquitinated cargo
If endosomal recruitment of Eps15 is physiologically rele-
vant, it must occur at reasonable levels of endosomal ubi-
quitin. Our finding that FLAG-Eps15 was recruited to
endosomes in GA-treated SK-BR-3 cells (Figure 1) showed
that artificially high, over-expressed levels of ubiquitinated
cargo were not required for this recruitment. As another
approach to this question, we took advantage of our find-
ing that Hrs was not required for recruitment of FLAG-
Eps15 to endosomes in GFP-FYVE-UbΔGG-expressing
cells (Figure 4). As Hrs is required for packaging of ubi-
quitinated proteins into MVBs [30], endogenous ubiquiti-
nated cargo should accumulate on endosome rims upon
Hrs silencing. For this reason, we next examined the
localization of FLAG-Eps15 in Hrs-silenced COS-7 cells.
FLAG-Eps15 was recruited to endosomes in these cells,
but not in control cells (Figure 4D, E), showing that en-
dogenous ubiquitinated cargo was sufficient for this
recruitment.
In some early experiments, we noticed that GFP-Rab5,
expressed to serve as an endosome marker, recruited
FLAG-Eps15 to endosomes. This recruitment was even
more pronounced when FLAG-Eps15 was co-expressed
with the constitutively-active GFP-Rab5Q79L mutant
(Figure 4F, G). We do not know the basis of this recruit-
ment. However, Rab5Q79L enhances early endosome
function, causing enlargement of endosomes [45], and is
Figure 5 Eps15 silencing does not affect ErbB2 degradation in
GA-treated SK-BR-3 cells. A. SK-BR-3 cells were transfected with
siRNA targeting Eps15 or a control siRNA as indicated. Proteins in
equal volumes of cell lysate were separated by SDS-PAGE and
analyzed by Western blotting, probing with anti-Eps15 and then
anti-Hsp70 antibodies. B. Triplicate dishes of SK-BR-3 cells transfected
with siRNA targeting Eps15, or a control siRNA, were incubated with
5 μM GA for the indicated times, lysed, and subjected to SDS-PAGE
and Western blotting. Equal volumes of each lysate were loaded on
the gel. Blots were probed with anti-ErbB2 or anti-Hsp70 antibodies,
and then with HRP-conjugated secondary antibodies for detection
by chemiluminescence. C. SK-BR-3 cells were transfected and
processed as in B, except that blots were probed with AF-680-
conjugated secondary antibodies for quantitation of bands using
the Odyssey infrared imaging system and the associated software.
Results shown are the average of 3 separate experiments, +/− SEM.
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[46]. We speculate that this may delay processing of ubi-
quitinated cargo in endosomes, allowing it to accumu-
late to levels high enough to recruit FLAG-Eps15.
siRNA suppression of Eps15 does not affect ErbB2
degradation
Eps15 might function in endosomes by aiding the
ESCRT-0 complex in collecting ubiquitinated cargo for
degradation. To test this idea, we examined the effect of
Eps15 silencing on degradation of ubiquitinated ErbB2.
We chose ErbB2, rather than EGFR, because Eps15 af-
fects EGFR internalization from the plasma membrane
[3,4]. Although this effect may be small [29], it makes it
harder to determine whether Eps15 also has a second
role in EGFR trafficking at endosomes. By contrast, ubi-
quitinated ErbB2 bypasses the Eps15-dependent step at
the plasma membrane, as it is internalized by a clathrin-
independent pathway [33]. Following delivery to endo-
somes, however, ubiquitinated ErbB2, like ubiquitinated
EGFR, is efficiently packaged into vesicles inside MVBs
[37].
Roxrud et al. reported that siRNA directed against a se-
quence present in both Eps15 and Eps15b delayed EGFR
degradation in HeLa cells, while an siRNA that targeted a
sequence present only in Eps15 had no effect [29]. We
tested an siRNA that targeted a sequence present in both
Eps15 and Eps15b [29], used previously by others to sup-
press Eps15 expression [38,47]. This siRNA suppressed
expression of full-length (150 kDa) Eps15 by about 80% in
SK-BR-3 cells (Figure 5A). We could not reproducibly de-
tect the 120 kDa Eps15b band on Western blots of lysates
from a typo for SK-BR-3 or COS-7 cells using our anti-
bodies, so we could not assess the efficacy of Eps15b silen-
cing (not shown). Nevertheless, silencing Eps15 did not
affect ErbB2 degradation in GA-treated SK-BR-3 cells
(Figure 5B, C) and Eps15 expression was not affected with
GA treatment (Additional file 8: Figure S8).
GFP-FYVE-UbΔGG slows endocytosis of EGFR and
transferrin receptor
Our current working model is that Eps15 recruitment to
ubiquitin-rich endosomes may function to sequester the
protein away from the plasma membrane. This might pro-
vide a feedback mechanism, slowing clathrin-mediated
endocytosis when high amounts of ubiquitinated cargo
were delivered to endosomes. This could provide time for
the ESCRT machinery to clear the ubiquitinated proteins,
preventing excessive over-accumulation in endosomes. As
a preliminary test of this idea, we measured internalization
of endogenous EGFR and transferrin receptor in SK-BR-3
cells expressing GFP-FYVE-UbΔGG. We first found
that steady-state levels of both receptors at the plasma
membrane were similar in GFP-FYVE-UbΔGG-expressingand control cells (Figure 6A, D). However, GFP-FYVE-
UbΔGG expression slowed internalization of both
AF-594-transferrin (Figure 6B) and anti-EGFR anti-
bodies (Figure 6E). Quantitation is shown in Figure 6C
and F. Interestingly, ubiquitin-dependent recruitment
of Eps15 to endosomes affected the rate of transferrin
receptor and EGFR endocytosis, but not cell surface
levels. It is possible that receptor recycling might par-
tially compensate for an altered internalization rate. It
is also possible that we could not measure a small in-
crease in plasma membrane levels of these receptors.
Because of membrane infoldings and uneven morphology,
quantitation of plasma membrane fluorescence may be
slightly less accurate than that of internalized material.
This result is consistent with our model that ubiquitin-
dependent recruitment of Eps15 to endosomes might slow
endocytosis by reducing the amount of the protein at the
plasma membrane. However, much further work will be
Figure 6 GFP-FYVE-UbΔGG expression inhibits endocytosis of EGFR and transferrin receptor in SK-BR-3 cells. GFP or GFP-FYVE-UbΔGG as
indicated was expressed in SK-BR-3 cells. A,D. AF-594 transferrin (A) or anti-EGFR antibodies (D) were bound to cells at 4°C, as detailed in
Methods, before fixation. B, E. AF-594 transferrin (B) or anti-EGFR antibodies (E) were allowed to internalize at 37°C as detailed in Methods. A,B,D,
E; Cells were processed for fluorescence microscopy as in Figure 1, except that cells shown in A, B, and D were not permeabilized. Tfn, transferrin.
Scale bars; 10 μm. D, E. Anti-EGFR antibodies were detected with AF-594-goat anti-mouse IgG. C, F. AF-594-transferrin (C) or AF-594 goat anti-
mouse IgG (F) fluorescence was quantitated as described in Methods. In each panel, MFI of cells with surface-bound probes is shown on the left;
MFI of cells containing internalized fluorophores is on the right. Values for GFP-expressing cells are shown with gray bars; values for GFP-FYVE-
UbΔGG-expressing cells are shown with black bars. Results shown are the average of 2 separate experiments, +/− SEM. The data were compared
using a one-way ANOVA test (***p < 0.0001).
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that GFP-FYVE-UbΔGG overexpression might have other
unanticipated effects on endosomal dynamics, possibly by
interfering with normal endosome funtion, that could
contribute to the observed inhibition of endocytosis sec-
ondarily. Furthermore, Eps15 may not be the only clathrin
coat accessory protein whose recruitment to endo-
somes might contribute to inhibition of endocytosis.
Endosomal ubiquitin could also recruit other ubiquitin-
binding accessory proteins, further inhibiting endocytosis.
Discussion
It is not known how Eps15 is recruited to endosomes in
response to EGFR signaling [18,19]. As EGF stimulates
tyrosine phosphorylation of the receptor itself, of Eps15,and of other substrates, and also leads to EGFR ubiquiti-
nation, any of these events might recruit Eps15 to endo-
somes. It is also not known whether the endosomal Eps15
binding partner Hrs is required for this recruitment.
In this paper, we showed that Eps15 was recruited to
endosomes enriched in ubiquitinated cargo. Recruitment
did not require Eps15 Tyr850, which is phosphorylated by
EGFR, or Hrs, but required the UIM domains of Eps15.
Furthermore, Eps15 showed UIM-domain-dependent re-
cruitment to novel ubiquitin-rich plasma membrane clus-
ters. Together, these findings suggest that binding of
Eps15’s UIM domains to ubiquitin can determine its
localization in the cell, and that EGF treatment can recruit
Eps15 to endosomes by causing ubiquitinated EGFR to ac-
cumulate there.
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endosomes [29]. Eps15b binds Hrs and colocalizes with
Hrs in microdomains on endosomes. Roxrud et al. sug-
gested that while EH domain interactions and AP-2
binding target Eps15 to the plasma membrane, Eps15b
is targeted to endosomes by binding to Hrs [29]. In con-
trast, Mayers et al. recently found that binding of the C.
elegans homolog of human Eps15, EHS-1, bound to Hrs
via the EH domains located on the amino terminus of
the protein [32]. Taken together, this suggests the UIM-
dependent, Hrs-independent targeting of Eps15 to
ubiquitin-rich endosomes that we observed occurs by a
different mechanism than constitutive, Hrs-dependent
endosomal targeting of Eps15b.
Our findings on ubiquitin-dependent Eps15 targeting
are very similar to behavior of epsin reported previously
by Chen and DeCamilli [36]. As we found for Eps15, epsin
could be recruited to endosomes or other cellular sites in
response to ubiquitin accumulation, in a UIM-dependent
manner. However, behavior of the two proteins differed in
one key way. Epsin, unlike Eps15, binds directly to clathrin
[3]. Epsin was only recruited to ubiquitin-enriched endo-
somes when clathrin binding was prevented, either by mu-
tation of epsin or silencing of clathrin [36]. By contrast,
we found that intact Eps15 was readily recruited to
ubiquitin-rich endosomes. Both Eps15 and epsin have
multiple binding partners at the plasma membrane, and
these interactions probably counteract UIM-dependent
targeting to endosomes, as shown for clathrin binding by
epsin [36]. Eps15 localization is also probably determined
by the balance of affinities for its various binding partners.
However, our results suggest that UIM domain interac-
tions are more likely to prevail in determining localization
of Eps15 than of epsin. Although the affinity of individual
UIM domains for ubiquitin is low [44], Eps15 can form di-
mers and tetramers via its coiled-coil domain [43]. Thus,
increasing the local concentration of ubiquitin should
greatly increase the avidity of Eps15 oligomers for
ubiquitin-rich sites. Our results suggest that this is enough
to recruit Eps15 to ubiquitin-rich endosomes. Thus,
ubiquitin-dependent targeting appears to occur more eas-
ily for Eps15 than for epsin, and may be more likely to
play an important physiological role.
In this context, a significant question is whether the
ubiquitin-dependent recruitment we observed occurs at
physiological levels of Eps15. This is an especially import-
ant concern because all our experiments were done using
over-expressed Eps15 constructs. It is possible that over-
expressed Eps15 might saturate its normal plasma mem-
brane binding partners, artificially creating a pool available
for recruitment to endosomes. For this reason, we care-
fully examined endosomal recruitment in cells expressing
the lowest detectable level of FLAG-Eps15 (Additional
file 2: Figure S2). We saw the same recruitment of FLAG-Eps15 to ubiquitin-rich endosomes at all levels of FLAG-
Eps15 expression, suggesting that endosomal recruitment
is not an artifact of overexpression.
Several functions for endosomal recruitment of Eps15
can be imagined. One obvious possibility is to aid the
ESCRT-0 complex in processing ubiquitinated cargo for
degradation. This could occur by direct binding of Eps15
to ubiquitinated cargo, and/or by establishment of a
ubiquitin-dependent protein network analogous to that at
the plasma membrane [10,24]. Our finding that Eps15 si-
lencing did not affect ErbB2 degradation (Figure 5) argues
against this possibility, and suggests that Eps15 is not
uniquely required for degradation of ubiquitinated cargo.
However, our findings do not exclude this possibility.
Eps15 overlaps functionally with the related adaptor
Eps15R and epsin at the plasma membrane [38]. Eps15R,
and possibly even epsin, might be recruited to endosomes
to substitute for Eps15 after its silencing.
Roxrud et al. found that silencing of Eps15 with an
siRNA that spared Eps15b did not affect EGFR degrad-
ation. By contrast, an siRNA targeting a sequence present
in both Eps15 and Eps15b delayed EGFR degradation [29].
These results suggested that Eps15b, but not Eps15, par-
ticipates in EGFR degradation. The siRNA that we used
was directed against a sequence present in both Eps15
and Eps15b. Thus, our results appear to contrast with
those of Roxrud et al. [29]. However, we could not repro-
ducibly detect Eps15b on Western blots, probably because
of the cell types and/or anti-Eps15 antibodies we used.
Thus, we could not tell how well our siRNA suppressed
Eps15b expression. Roxrud et al. reported more efficient
suppression of Eps15 than Eps15b, despite using siRNA
that targeting a shared sequence [29]. If the same were
true for the siRNA we used, sufficient Eps15b might have
remained to aid in ErbB2 degradation.
Conclusions
Here, we show for the first time that ubiquitin alone is
sufficient for Eps15 recruitment to endosomes. Although
the function of this targeting remains unclear, our find-
ings suggest the following possibility. Extensive delivery
of ubiquitinated cargo to endosomes might saturate the
ESCRT machinery, causing accumulation of ubiquiti-
nated proteins on the limiting membrane. Sequestration
of Eps15 away from its normal site of action at nascent
clathrin-coated pits might slow endocytosis, providing
time for the ESCRT complexes to catch up and package
cargo into the MVB interior in an orderly fashion.
Methods
Cells and transfection
COS-7 and SK-BR-3 cells were from American Type
Culture Collection (ATCC, Manassas, VA) and were cul-
tured in Dulbecco’s modified Eagle’s medium (DMEM;
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calf serum (JRH, Lenexa, KS) and penicillin/strepto-
mycin in a humidified incubator with 5% CO2 at 37°C.
SK-BR-3 cells were transiently transfected with Lipofec-
tamine 2000 (Invitrogen) in Optimem I reduced-serum
medium (Invitrogen) according to the manufacturer’s rec-
ommendation. COS-7 cells were transfected with either
Lipofectamine 2000 or 50 kDa poly (2-ethy)-2 oxazoline
(polyethylenimine; PEI; Sigma Aldrich, St. Louis, MO),
deacylated according to [48]. For PEI transfection, 1 μg
DNA and 6 μL 25 mM PEI were added to 0.1 ml of
0.15 M NaCl with vortexing, incubated at room
temperature for 10 min, and then added drop wise to
cells in normal growth media. Cells were then incu-
bated for 24 hours at 37°C before use.
Antibodies, fluorescent compounds, and other reagents
Mouse monoclonal anti-ErbB2 N28 used for cell-surface
detection in IF experiments was from LabVision (Fremont,
CA). Lab Vision mouse monoclonal anti-ErbB2 (Ab-20
cocktail) was used for Western blotting. Anti-FLAG anti-
bodies: for IF, rabbit polyclonal anti-DYKDDDDK was
from Pierce Antibodies, Thermoscientific (Rockford, IL).
For Western blotting, mouse monoclonal anti-FLAG® M2
antibody and rabbit polyclonal anti-GAPDH was from
Sigma-Aldrich. Mouse monoclonal anti-EEA1 and anti-
Eps15 (clone 17) were from BD Biosciences (San Jose,
CA). Mouse monoclonal anti-EGFR mouse (Ab-12 cock-
tail) was from Thermoscientific. Rabbit monoclonal
anti-EGFR (D38B1), anti-Akt (C67E7), anti-p-Akt (D9E),
anti-MAPK (137 F5), anti-p-MAPK (D13.14.4E) were
from Cell Signaling Technology (Danvers, MA). Anti-Hrs
(A-5) mouse monoclonal was from Alexis Biochemicals,
Enzo Life Sciences International, Inc. (Plymouth Meeting,
PA). Mouse monoclonal anti-Hsp70 was from Santa Cruz
Biotechnology, Inc. (Santa Cruz, CA). Mouse monoclonal
anti-Histone H3 (ab1791( was from Abcam (Cambridge,
MA). HRP-goat anti-mouse IgG and HRP-donkey anti-
rabbit IgG were from Jackson Immunoresearch (West
Grove, PA). AlexaFluor (AF)-488, AF-594, AF-647 and AF-
680-conjugated goat anti-mouse and goat anti-rabbit IgG
and AF-594-transferrin were from Invitrogen (Carlsbad,
CA). Other reagents: GA (used at 5 μM) was from the
Drug Synthesis and Chemistry Branch, National Cancer
Institute (Bethesda, MD). EGF was from Calbiochem,
EMD Biosciences.
Plasmids
pEGFP-N1 was from Clontech (Mountain View, CA).
Plasmids encoding FLAG-Eps15 and FLAG-Eps15-ΔUIM
[38], PM-GFP, PM-GFP-Ub and pEGFP-2xFYVE-UbΔGG
[36] were gifts of P. DeCamilli (Yale University, New
Haven, CT). pcDNA3 ErbB2-GFP [49] was the gift of
P. Liu (Univ. North Carolina, Chapel Hill, NC). Plasmidsencoding FLAG-Eps15-ΔI, FLAG-Eps15-ΔII, FLAG-
Eps15-ΔIII, FLAG-Eps15-ΔIV and FLAG-Eps15-Y850F
[42] were the gifts of E. Fon (McGill University, Montréal,
Canada). A constitutively-active GFP-Rab5-Q79L plas-
mid [50] was the gift of A. Levey (Emory University,
Atlanta GA).
Fluorescence microscopy
Cells were seeded on acid-washed glass coverslips in
35 mm dishes, transfected, and examined 1 day after
transfection. Cells were fixed in phosphate-buffered saline
(PBS; 150 mM NaCl, 20 mM phosphate buffer, pH 7.4)
containing 3% paraformaldehyde for 30 minutes, and
permeabilized at room temperature with PBS containing
0.5% Triton unless otherwise noted. The cells were then
blocked with Blocking Buffer (PBS containing 3% BSA
and 10 mM Gly). Primary and secondary antibodies were
diluted in Blocking Buffer. Cells were incubated with pri-
mary antibodies for 1 hour at room temperature, followed
by secondary antibodies for 30 minutes, also at room
temperature. Cells were photographed and images were
captured using a Zeiss inverted Axiovert 200 M micro-
scope with a two-photon laser scanning confocal system.
All images were acquired with a 100× oil immersion ob-
jective (N.A. = 4.5) and processed with Zeiss LSM soft-
ware. When necessary, images were further processed
using Adobe Photoshop, adjusting contrast and/or bright-
ness for optimal viewing. Each channel was adjusted sep-
arately and changes were applied to the whole field.
Colocalization analysis
Colocalization analysis of confocal images was per-
formed with NIH Image J (http://rsb.info.nih.gov/ij/) and
the JaCoP plug-in [51] as described previously [33].
Manders’ overlap coefficients were reported and can be
interpreted as percent colocalization. The statistical ana-
lysis of this data was performed using Graphpad.
Western blotting
Proteins were separated by sodium dodecyl sulfate poly-
acrylamide gel electrophoresis (SDS‐PAGE), and then
transferred to nitrocellulose for Western blotting and de-
tection on film by enhanced chemiluminescence as de-
scribed [52]. Where indicated, bands were scanned and
quantified using NIH ImageJ. For quantitating ErbB2
degradation, bands were labeled with AF-680-secondary
antibodies and detected and quantified with the Odyssey-
Infrared Imaging System (LI-COR Biosciences, Lincoln,
NE), using the Odyssey imaging software.
Immunoprecipitation of ErbB2
SK-BR-3 cells were treated with 5 μM for 1 hour prior to
the addition of lysis buffer (1% Triton-X-100, 0.15 M
NaCl, 2 mM EDTA, 50 mM NaF plus protease inhibitors).
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spun down for at 4°C for 15 minutes. Rabbit anti-
mouse coated protein A beads were added to the lysate
for 1 hour at 4°C. Samples were washed twice with
PBS, then one time with 25 mM Tris Cl, pH 7.4 before
adding Laemmli buffer, followed by Western blotting.siRNA silencing
siRNA duplex constructs targeting Hrs and Eps15 were
made using Stealth RNAi™ siRNA technology (Invitro-
gen). Eps15 was targeted using a sequence (AAACG
GAGCUACAGAUUAU) near the 3’ end of the coding
sequence, as previously described [38,47]. The targeted
sequences for Hrs were GCACGGUAUCUCAACCG
GAACUACU (siRNA-1), and CAGAAUCUCAUGAC
CACCCUCCCAA (siRNA-2). The Medium GC Stealth
RNAi™ siRNA Duplex (Invitrogen) was used as a control.
For Hrs knockdown, COS-7 cells were first transfected
with FLAG-Eps15 and GFP-FYVE-UbΔGG using Lipo-
fectamine 2000. After 5 hours, 50 nmole siRNA mixed
with additional Lipofectamine 2000 was added. After
24 hours, cells were trypsinized. Half of the cells were
replated in a 35 mm dish with a coverslip (for IF ana-
lysis); the other half were plated in a separate 35 mm
dish for Western blotting to confirm Hrs knockdown.
Cells were incubated for a further 24 hours before har-
vesting. For Eps15 knockdown, SK-BR-3 cells were
seeded in 35 mm dishes and transfected using Lipofecta-
mine 2000 and 100 nmole siRNA oligos in Optimem for
24 hours. After 24 hours, Optimem was replaced with
DMEM containing 10% calf serum. Cells were incu-
bated an additional 48 hours before assaying for ErbB2
degradation.Transferrin binding and internalization
To measure cell-surface transferrin receptor levels,
SK-BR-3 cells (transfected as described in the legend
to Figure 6) were incubated on ice for 2 hours with
50 μg/ml AF-594-transferrin in growth media, and
then processed for IF as described above. To measure
transferrin internalization, pre-warmed media contain-
ing 50 ng/ml transferrin was added to cells at 37°C for
5 minutes before fixation and processing for IF. Values
shown are averages from two separate experiments,
analyzing at least 50 cells on each slide. All images
were captured using the confocal microscope de-
scribed above. The same acquisition parameters were
used for all images to be compared quantitatively, and
images were not further processed after acquisition.
Mean intensity fluorescence (MFI) of individual cells
was calculated using the histogram macro on the Zeiss
LSM software.EGFR surface expression and internalization assays
Anti-EGFR antibodies (2 μg/ml) were bound to trans-
fected SK-BR-3 cells for 1 hour at 4°C. To quantitate
cell-surface EGFR, cells were fixed but not permeabilized
before incubation with AF-594 secondary antibodies and
processing for IF as described above. To measure EGFR
internalization, antibody-bound cells were incubated
with pre-warmed growth media containing 100 ng/ml
EGF for 10 minutes at 37°C. Residual surface-bound
antibodies were then stripped from cells on ice with acid
(100 mM Gly, 50 mM KCl, 20 mM MgOAc, pH 2.3),
using 3 washes of 3 minutes each. Cells were then fixed,
permeabilized, and incubated with AF-594 goat anti-
mouse IgG antibodies. The experiment was repeated 3
times, quantitating MFI of at least 10 cells per slide as
described above for transferrin experiments. Background
fluorescence, determined as the average MFI in the nu-
clei of 5 cells, was subtracted from all values for inter-
nalized EGFR.
Additional files
Additional file 1: Figure S1. ErbB2 is ubiquitinated following GA
treatment. SK-BR-3 cells were left untreated or incubated with 5 μM GA
for 1 hour, lysed, and immunoprecipitated with anti-ErbB2. Lysates were
then subjected to SDS-PAGE and Western blotting. Blots were probed
with anti-ErbB2 (top panel) and anti-ubiquitin (bottom panel), and then
with HRP-conjugated secondary antibodies for detection by
chemiluminescence.
Additional file 2: Figure S2. GA does not activate Akt or MAPK. SK-BR-
3 cells were either serum starved and treated with 100 ng/ml EGF for 45’
at 37°C, or treated with 5 μM GA for the indicated times, lysed, and
subjected to SDS-PAGE and Western blotting. Equal volumes of each
lysate were loaded on the gel. Blots were probed with anti-Akt, anti-p-
Akt, anti-MAPK, anti-p-MAPK and anti-Histone H3 antibodies (loading
control), and then with HRP-conjugated secondary antibodies for
detection by chemiluminescence.
Additional file 3: Figure S3. Endosomal recruitment of FLAG-Eps15 does
not depend on FLAG-Eps15 expression level. FLAG-Eps15 and EEA1 were
detected in FLAG-Eps15- and GFP-FYVE-UbΔGG-transfected COS-7 cells with
rabbit anti-FLAG and mouse anti-EEA1 antibodies and appropriate
secondary antibodies (AF-594 goat anti-rabbit IgG and AF-647 goat
anti-mouse IgG). The Manders’ overlap coefficient for colocalization of
Eps15 with EEA1 in each of 27 cells is plotted as function of the mean
AF-594 fluorescence intensity in the same cell.
Additional file 4: Figure S4. Cherry Eps15 is recruited to PM-GFP-Ub
and GFP-FYVE-UbΔGG. mCherry-Eps15 was co-expressed in COS-7 cells
with GFP (A), PM-GFP-Ub (B) or GFP-FYVE-UbΔGG (C), and cells were
processed for IF microscopy. Scale bars; 10 μm.
Additional file 5: Figure S5. Tyr 850 is not required for endosomal
recruitment of FLAG-Eps15. FLAG-Eps15 Y850F was co-expressed in
COS-7 cells with either GFP (top) or GFP-FYVE-UbΔGG (bottom), and cells
were processed for IF microscopy. FLAG-Eps15 Y850F was detected with
anti-FLAG antibodies and AF-594 goat anti-rabbit antibodies, while EEA1
was detected with anti-EEA1 antibodies and AF-647 goat anti-mouse
antibodies (pseudo-colored blue).
Additional file 6: Figure S6. Eps15 and Eps15 Y850F are recruited to
activated EGFR. FLAG-Eps15 and FLAG-Eps15 Y850F were expressed in
SK-BR-3 cells and were either left untreated, or stimulated with 100 ng/ml
EGF for 10’ at 37°C and then processed for IF microscopy. FLAG-Eps15
and FLAG-Eps15 Y850F were detected with anti-FLAG antibodies and
AF-594 goat anti-mouse antibodies, while endogenous EGFR with
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images are shown at the right with DAPI staining. Scale bars; 10 μm.
Additional file 7: Figure S7. Hrs is not required for recruitment of Eps15
to PM-GFP-Ub or GA-treated ErbB2. A. COS-7 cells were transfected with
siRNA targeting Hrs or a control siRNA, FLAG-Eps15 and PM-GFP-Ub as
indicated. Proteins in equal volumes of cell lysate were separated by
SDS-PAGE and analyzed by Western blotting, probing with anti-Hrs and
then anti-GAPDH antibodies. C. SK-BR-3 cells transfected with siRNA
targeting Hrs, or a control siRNA, FLAG-Eps15 and ErbB2-GFP and
incubated with 5 μM GA for 4 hours, lysed, and subjected to SDS-PAGE
and Western blotting. Equal volumes of each lysate were loaded on the
gel. Blots were probed with anti-Hrs or anti-GAPDH antibodies, and
then with HRP-conjugated secondary antibodies for detection by
chemiluminescence. B,D. Cells transfected with the indicated constructs
were processed for IF microscopy, staining with anti-FLAG and AF-594
goat anti-rabbit IgG to detect FLAG-Eps15. Merged images are shown
at the right. Scale bars; 10 μm.
Additional file 8: Figure S8. Representative Western Blot of Eps15 RNAi.
A. SK-BR-3 cells transfected with siRNA targeting Eps15, or a control siRNA,
were incubated with 5 μM GA for the indicated times, lysed, and subjected
to SDS-PAGE and Western blotting. Equal volumes of each lysate were
loaded on the gel. Blots were probed with anti-ErbB2, anti-Eps15 or anti-
Hsp70 antibodies, and then with HRP-conjugated secondary antibodies for
detection by chemiluminescence. B. Quantitation of bands was performed
using the Odyssey infrared imaging system and the associated software.
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